NCT07285330

Brief Summary

The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

10 months

First QC Date

December 3, 2025

Last Update Submit

December 3, 2025

Conditions

Keywords

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

  • Glycate hemoglobin

    Glycated hemoglobin (HbA1c) levels three months after completion of the intervention

    three months after completion of the intervention

Study Arms (2)

Day Care Hospital

These patients received joint care from a nurse and an endocrinologist in the day hospital before 2024.

Other: Day Care Hospital

Nutritionist

These patients received joint care from a nutriotinist and finally an endocrinologist in ambulatory care unit after 2024.

Other: Nutritionist

Interventions

Clinical follow-up under the joint care of a nurse and an endocrinologist at Day Care Hospital

Day Care Hospital

Clinical follow-up with a dietitian-nutritionist and an endocrinologist at ambulatory care unit

Nutritionist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients affected by diabetes mellitus type 2

You may qualify if:

  • Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
  • Patients on insulin therapy

You may not qualify if:

  • Referred from primary care for other reasons such as hypoglycemia.
  • Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
  • Patients on rapid-acting insulin bolus therapy.
  • Patients with acute decompensation of diabetes.
  • Patients receiving corticosteroid treatment.
  • Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
  • Language barrier.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de Vilafranca

Vilafranca del Penedès, Barcelona, 08720, Spain

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus

Interventions

Nutritionists

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Health PersonnelHealth Care Facilities Workforce and Services

Central Study Contacts

Noemí Casaponsa

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 3, 2025

First Posted

December 16, 2025

Study Start

June 30, 2025

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will share

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Shared Documents
STUDY PROTOCOL
Time Frame
After publication of main results of the study.
Access Criteria
IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

Locations